| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 18 |
| 1 | ALPRAZOLAM | 16 |
| 2 | ERGOCALCIFEROL | 16 |
| 3 | FLUOXETINE HYDROCHLORIDE | 16 |
| 4 | ASPIRIN | 15 |
| 5 | ASPIRIN 325 MG | 15 |
| 6 | ASPIRIN 81 MG | 15 |
| 7 | ESTRADIOL | 15 |
| 8 | ZOLPIDEM TARTRATE | 15 |
| 9 | ESTRADIOL GEL 0.1% | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 1 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 2 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 2 | 0.0018 |
| 3 | RALTEGRAVIR | 9 | 0.0017 |
| 4 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 6 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 7 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 8 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 3 | 0.0010 |
| 9 | RILONACEPT | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 48 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 2 | Corticosteroid [EPC] | 25 |
| 3 | Atypical Antipsychotic [EPC] | 22 |
| 4 | Estrogen [EPC] | 19 |
| 5 | Provitamin D2 Compound [EPC] | 16 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 13 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 13 |
| 9 | Vitamin C [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 7 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 8 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 9 | Serotonin Reuptake Inhibitor [EPC] | 13 | 0.0001 |